Selected article for: "China mainland and rapidly spread"
Author: Xiang Bai; Cong Fang; Yu Zhou; Song Bai; Zaiyi Liu; Qianlan Chen; Yongchao Xu; Tian Xia; Shi Gong; Xudong Xie; Dejia Song; Ronghui Du; Chunhua Zhou; Chengyang Chen; Dianer Nie; Dandan Tu; Changzheng Zhang; Xiaowu Liu; Lixin Qin; Weiwei Chen
Title: Predicting COVID-19 malignant progression with AI techniques
  • Document date: 2020_3_23
    • ID: 50oy9qqy_1
    Snippet: In mid-December 2019, the ongoing coronavirus disease 2019 broke out in Wuhan and spread rapidly in the mainland of China (80813 cases, updated through March 12, 2020) . So far, the infection had burst in countries outside China, evolving into a pandemic 4,5 . According to the Chinese epidemic data, the mild, severe, and critical types of COVID-19 were 81%, 14%, and 5% separately 6 . More seriously, as of 12 March, the mortality of COVID-19 was 3.....
    Document: In mid-December 2019, the ongoing coronavirus disease 2019 broke out in Wuhan and spread rapidly in the mainland of China (80813 cases, updated through March 12, 2020) . So far, the infection had burst in countries outside China, evolving into a pandemic 4,5 . According to the Chinese epidemic data, the mild, severe, and critical types of COVID-19 were 81%, 14%, and 5% separately 6 . More seriously, as of 12 March, the mortality of COVID-19 was 3.93% (3176/80813) in the mainland of China, even reached 4.87% (2436/49991) in Wuhan City, which was much higher than that of other influenza 7, 8 . In addition, the clinical course of COVID-19 varied individually. In order to prevent malignant progression and reduce the mortality of COVID-19, it is vital to identify mild patients who are easy to deteriorate into severe/critical cases and give them active treatment earlier.

    Search related documents:
    Co phrase search for related documents
    • active treatment and mild patient: 1, 2
    • active treatment and mortality reduce: 1, 2, 3, 4, 5, 6, 7
    • active treatment and rapidly spread: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • China mainland and clinical course: 1, 2, 3
    • China mainland and critical type: 1
    • China mainland and mild patient: 1
    • China mainland and mortality reduce: 1, 2, 3, 4, 5, 6, 7
    • China mainland and rapidly spread: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
    • China mainland and severe critical case: 1, 2, 3
    • clinical course and critical type: 1, 2, 3, 4, 5, 6, 7
    • clinical course and mild patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23
    • clinical course and mortality reduce: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • clinical course and pandemic evolve: 1
    • clinical course and rapidly spread: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42
    • clinical course and severe critical case: 1
    • clinical course and severe mild critical type: 1
    • critical type and mild patient: 1, 2, 3
    • critical type and mortality reduce: 1, 2, 3, 4
    • critical type and rapidly spread: 1, 2, 3, 4